Hand Foot and Mouth Disease Limited Appeal For Pharmaceutical Investment
This article was originally published in PharmAsia News
Executive Summary
Since early this year, the spread of hand foot and mouth disease in China's Fuyang city and other areas has spurred the sales of domestic antiviral products, drawing the attention of venture capitalists. Several securities companies believe there are investment opportunities, sparking a rise in pharmaceutical shares in recent days. However, analysts caution that such spikes may have close relationship with the Sichuan earthquake. HFMD may drive sales in the short term but has limited impact since the disease is relatively easy to treat. (Click here for more - Chinese Language)